During the past decade, Parexel - Early Phase Clinical Unit conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Parexel - Early Phase Clinical Unit" #1 sponsor was "Astellas Pharma Global Development, Inc." with 5 trials, followed by "B. Braun Medical Inc." with 1 trials sponsored, "Elixiron Immunotherapeutics Inc." with 1 trials sponsored, "MassBiologics" with 1 trials sponsored and "Nivalis Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Parexel - Early Phase Clinical Unit" #1 collaborator was "Basilea Pharmaceutica International Ltd" with 2 trials as a collaborator, "Parexel" with 2 trials as a collaborator and "Janssen Biotech, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Parexel - Early Phase Clinical Unit" are "Healthy Subjects" (3 trials), "Healthy Volunteers" (3 trials), "Autism Spectrum Disorder" (1 trials), "Bioavailability of ASP015K" (1 trials) and "Circadian Rhythm Sleep Disorders" (1 trials). Many other conditions were trialed in "Parexel - Early Phase Clinical Unit" in a lesser frequency.

Most popular intervention types in "Parexel - Early Phase Clinical Unit" are "Drug" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Isavuconazole" (2 trials), "0.9% Sodium Chloride (NaCl)" (1 trials), "ASP015K" (1 trials) and "Caffeine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Parexel - Early Phase Clinical Unit" are 9 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Parexel - Early Phase Clinical Unit". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Parexel - Early Phase Clinical Unit, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Parexel - Early Phase Clinical Unit, 10 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".